ArticleClinical and translational science2025

Trends in and Determinants of Approval Lag for Anticancer Drugs in Japan and the US: Role of Multi-Regional Trials and Concurrent Approvals.

Hitoshi Kanno et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.